Can we predict relapse in Graves’ disease? Results from a systematic review and meta-analysis
European Journal Of EndocrinologyTristan Struja +62016Journals
Identification of pretreatment risk factors predicting relapse in patients with hyperthyroidism of Graves' disease after stopping anti-thyroid drugs (ATD) is decisive to guide therapeutic options.
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support